For example, FGFR4 mutations were common in KIRC and SKCM (Figure 3A), whereas the common target mutations in STAD occurred in FGFR2 and VEGFR3 (Figure 3B). This evidence concerns the gene FLT4 and gastric adenocarcinoma.